Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel sulfonyl-pyrrolidine route for Brivaracetam. Reduces chiral separation costs and simplifies purification for scalable API manufacturing.
Novel Ni(II)-SNC catalyst enables high-yield sulfide oxidation under mild conditions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN112921345B reveals a green electrochemical route for phosphorothioates, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN104045513A reveals cost-effective Empagliflozin intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN116284117A introduces a green electrochemical route for thiophosphoramides, offering cost reduction and high purity for pharmaceutical and agrochemical manufacturing.
Novel room-temperature copper catalysis for polychlorinated alkynes. Reduces energy costs and simplifies purification for high-purity pharmaceutical intermediates.
Novel patent CN116478026B offers high-yield tropone skeleton synthesis. Reduces costs and simplifies supply chain for pharmaceutical intermediates manufacturing.
Patent CN102249969A discloses a high-regioselective iridium-catalyzed method for phenyl-(3-aryl-2-propenyl) selenides, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116041207A reveals a novel chiral spiroindane ligand enabling high-selectivity C-H activation. Discover cost-effective synthesis and supply chain advantages.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Novel microchannel nitration process for irinotecan intermediate ensures safety and yield. Supply chain reliability improved via intrinsic safety design and reduced waste discharge for global buyers.
Novel 5-step synthesis of ent-chromazonarol from sclarealdehyde. Reduces steps vs prior art. Suitable for industrial scale-up and supply chain stability.
Patent CN101255171A reveals a safer carbapenem intermediate process eliminating toxic organotin. Achieve cost reduction and supply reliability.
Patent CN103012292A reveals a novel 2-step synthesis for dibenzo[b,f][1,2]diazocine, offering >50% yield and eliminating toxic mercury residues for reliable pharmaceutical intermediate supply.
Novel patent CN115504866B offers high-yield 4-methoxy-2-naphthol synthesis. Improves supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel crystallization method ensures 99.9% purity for Bilastine. Reduces impurities and enhances stability for reliable pharmaceutical supply chains.
Patent CN119039150A details a novel Negishi coupling route for high-purity Cobicistat intermediates, offering significant supply chain and cost advantages for manufacturers.
Patent CN116554054B reveals efficient styrene-based synthesis for ketoprofen and loxoprofen intermediates offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel two-step synthesis from styrene reduces cost and improves purity for pharmaceutical manufacturing supply chains.
Patent CN113493405B reveals solid intermediate route for Milrinone. Enhances purity and safety for scalable pharmaceutical intermediate manufacturing supply chains.